Literature DB >> 6155430

The role of host responses in the recovery of mice from Sendai virus infection.

M J Anderson, J R Pattison, R J Cureton, S Argent, R B Heath.   

Abstract

The antiviral responses in mice to intranasal inoculation with Sendai virus are described. To investigate the relative importance of the humoral, cell-mediated and interferon responses, the pathogenesis of this infection was studied in animals which were immunocompetent, T cell-deprived or immunosuppressed with cyclophosphamide. Treatment with cyclophosphamide converted the mild, self-limiting infection observed in immunocompetent mice into a severe and frequently lethal pneumonic disease. This was associated with an enhanced interferon response but no detectable antibody or cell-mediated immune response. T cell-deprived mice suffer an infection of intermediate severity associated with an increased interferon response, a normal humoral immune response and no cell-mediated immune response. The implications of these results in relation to the role of the antiviral responses in recovery from Sendai virus infection are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155430     DOI: 10.1099/0022-1317-46-2-373

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Genetic determinants of lung virus titers and resistance to lethal Sendai virus pneumonia.

Authors:  D G Brownstein; S Winkler
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Viral infection enhances the response to Saccharopolyspora rectivirgula in mice prechallenged with this farmer's lung antigen.

Authors:  Y Cormier; N Samson; E Israël-Assayag
Journal:  Lung       Date:  1996       Impact factor: 2.584

3.  Sendai virus infection in genetically resistant and susceptible mice.

Authors:  D G Brownstein; A L Smith; E A Johnson
Journal:  Am J Pathol       Date:  1981-11       Impact factor: 4.307

4.  Genetics of natural resistance to Sendai virus infection in mice.

Authors:  D G Brownstein
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

5.  Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infection.

Authors:  Kymberly M Gowdy; Tereza Martinu; Julia L Nugent; Nicholas D Manzo; Helen L Zhang; Francine L Kelly; Michael J Holtzman; Scott M Palmer
Journal:  Transpl Immunol       Date:  2014-11-05       Impact factor: 1.708

6.  Spread of vesicular stomatitis virus along the visual pathways after retinal infection in the mouse.

Authors:  B Lundh
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Authors:  Bart Jones; Xiaoyan Zhan; Vasiliy Mishin; Karen S Slobod; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2009-02-04       Impact factor: 3.641

8.  Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.

Authors:  M Tashiro; M Homma
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Cell-mediated immunity induced in mice after vaccination with a protease activation mutant, TR-2, of Sendai virus.

Authors:  M Tashiro; Y Fujii; K Nakamura; M Homma
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  Sendai virus glycoproteins are T cell-dependent B cell mitogens.

Authors:  S Kizaka; G Goodman-Snitkoff; J J McSharry
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.